13F

Stock

Cocrystal Pharma, Inc.

COCP · held by 29 managers

Reported value

$754.3K

Holders

29

+0 new · −1 exited

Holders’ est. mark

−$2.72K

Price effect on 2 books still in the name

Largest holder

$258.4K

Vanguard

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Vanguard264K$258.4KHeld
Renaissance Technologies126K$123.4KHeld
GEODE CAPITAL MANAGEMENT, LLC82.5K$80.8KHeld
BlackRock, Inc.73.7K$72.2KHeld
T3 Companies, LLC52.3K$51.2KHeld
DRW Securities, LLC33.6K$32.9KHeld
NEUBERGER BERMAN GROUP LLC31.9K$31.2KHeld
State Street20.5K$20.1KHeld
XTX Topco Ltd15.1K$14.8KHeld
TWO SIGMA SECURITIES, LLC12.8K$12.5KHeld
Parallel Advisors, LLC12.6K$12.3KHeld
NORTHERN TRUST CORP11.9K$11.7KHeld
JANE STREET GROUP, LLC10.6K$10.4KHeld
BANK OF AMERICA CORP /DE/9.08K$8.89K−$2.46KCut−$2.47K
Tower Research Capital LLC (TRC)5.1K$4.99KHeld
Fortitude Family Office, LLC3.22K$3.15KHeld
UBS Group AG1.78K$1.74KHeld
MORGAN STANLEY948$928−$257Cut−$6.4K
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO817$800Held
WELLS FARGO & COMPANY/MN788$772Held
Clean Yield Group418$409Held
CITIGROUP INC390$382Held
MAI Capital Management237$233Held
NVWM, LLC84$82Held
SBI Securities Co., Ltd.33$32Held
Root Financial Partners, LLC7$7Held
ROYAL BANK OF CANADA51$0Held
Motiv8 Investments LLC42$0Held
Fidelity0$0Held

Who left

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.